As per MRFR analysis, the Pharmaceutical Gelatin Market Size was estimated at 3.21 (USD Billion) in 2023. The Pharmaceutical Gelatin Market Industry is expected to grow from 3.35(USD Billion) in 2024 to 5.4 (USD Billion) by 2035. The Pharmaceutical Gelatin Market CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025-2035).
A number of notable market drivers are fueling growth in the Global Pharmaceutical Gelatin Market. The growing population of health-conscious consumers and those adhering to specific dietary restrictions is a significant factor contributing to the growth of the capsule industry, particularly the demand for vegetarian gelatin alternatives. Innovative developments in formulation technologies that improve the stability and efficacy of pharmaceutical products are also stimulating innovation in the gelatin industry.
Regulatory support is also significant in a variety of regions, as governments are increasingly emphasizing safety standards and quality regulations that reinforce consumer confidence in gelatin-based products utilized in the pharmaceutical sector. Opportunities for the expansion of gelatin applications beyond traditional pharmaceuticals, such as in nutraceuticals and specialty food products, are present due to the increasing consumer preference for clean-label ingredients. This is in the context of these trends. In addition, the growing demand for personalized medications is establishing the groundwork for customized gelatin formulations, which could offer a competitive edge.
In recent years, there has been a significant increase in research and development activities in the pharmaceutical gel market, which is indicative of a broader consumer trend toward sustainability. These activities are focused on the development of pharmaceutical gels that involve natural and organic sources. It is important to note the transition to biocompatible materials in drug delivery systems.In addition, the increasing preference for production methods that reduce environmental impact is consistent with global sustainability objectives, suggesting a change in consumer expectations and regulatory compliance. Overall, these changing trends indicate that the Global Pharmaceutical Gelatin Market will have a dynamic future that is defined by its adaptability and innovation in response to consumer demands.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Pharmaceutical Gelatin Market Industry is experiencing a notable surge in demand for gelatin capsules and other gelatin-based pharmaceutical products. This demand is primarily driven by the growing trend among consumers preferring capsules over traditional tablets due to benefits such as easier ingestion and better absorption. In a survey conducted by the Food and Drug Administration, it was indicated that gelatin capsules have captured about 50% market share in the oral dosage forms segment.
With key companies like Gelita AG and PB Gelatins leading the market, they are likely to benefit from this growing trend as pharmaceutical companies increasingly lean towards gelatin capsules to provide their customers with an enhanced experience. Moreover, rising health consciousness among consumers and a shift towards preventive healthcare has further stimulated the requirements for gelatin-based formulations, propelling the growth of the Global Pharmaceutical Gelatin Market Industry.The rising manufacturing capacity among major players is also pivotal in supporting this growing demand.
The increase in the geriatric population worldwide is another significant driver for the Global Pharmaceutical Gelatin Market Industry. The World Health Organization reports that by 2050, the number of people aged 60 years and older is projected to reach 2 billion, which signifies a rising need for pharmaceuticals tailored to older individuals. The elderly often prefer softer dosage forms, such as capsules, which are generally filled with gelatin. This trend is expected to lead to increased demand for gelatin-based products as pharmaceutical firms like Pfizer Inc. and Johnson Johnson enhance their focus on developing medications suited for the aging demographic. The corresponding expansion of healthcare facilities aimed at older populations further accelerates this requirement, thereby boosting growth in the Global Pharmaceutical Gelatin Market Industry.
The Global Pharmaceutical Gelatin Market Industry is poised for growth due to the increasing investment in biopharmaceuticals and vaccines. According to the Biotechnology Innovation Organization, the biopharmaceutical sector is expected to grow by about 7.4% annually, driven by innovation in drug formulation technologies. Gelatin is gaining prominence in the formulation of biologics and vaccines due to its stabilizing properties—leading companies such as Merck Co. Novartis is investing heavily in the development of biologics that incorporate gelatin, which is recognized for its efficient encapsulation capabilities. The ongoing pandemic has also emphasized the need for vaccines, thus creating new opportunities for gelatin use in vaccine production. This trend indicates a significant avenue for advancement and expansion within the Global Pharmaceutical Gelatin Market Industry.
The Global Pharmaceutical Gelatin Market is witnessing robust growth, particularly driven by its application across various forms, including Capsules, Tablets, Suppositories, and Vaccines. The market is expected to see a significant valuation of 3.35 USD Billion in 2024, with the Application segment playing a critical role in this growth trajectory. Capsules are anticipated to hold a major share of the market, valued at 1.2 USD Billion in 2024 and projected to increase to 1.95 USD Billion by 2035, reflecting their popularity owing to their ease of ingestion and ability to mask unpleasant tastes.
Tablets also represent a significant portion, valued at 1.0 USD Billion in 2024, with a rise to 1.55 USD Billion forecasted for 2035, showcasing their longstanding use in pharmaceuticals as a reliable dosage form. In the segment of Suppositories, the market value is recorded at 0.8 USD Billion in 2024, expected to rise to 1.15 USD Billion by 2035, highlighting their niche yet vital role in delivering medications directly into the systemic circulation. Lastly, Vaccines contribute to the market with a valuation of 0.35 USD Billion in 2024, predicted to reach 0.75 USD Billion by 2035, emphasizing their essential function in public health initiatives and immunization programs. The significant market revenue for Capsules and Tablets underscores their dominance in the pharmaceutical industry, where ease of use, patient compliance, and effectiveness are integral to therapeutic outcomes.
This growth in the Application segment is further fueled by increasing health awareness, aging populations, and advancements in drug formulation technologies, creating vast opportunities along with the challenges posed by regulatory requirements and the need for innovation. The Global Pharmaceutical Gelatin Market data reflects a trend toward the demand for higher quality, more effective, and patient-friendly formulations, serving to propel the industry forward as it evolves to meet consumer and healthcare needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Pharmaceutical Gelatin Market, categorized by Source, encompasses various types, including Porcine, Bovine, and Fish, each playing a crucial role in the industry. As of 2024, the market is valued at 3.35 billion USD, showing significant growth potential as it is expected to reach 5.4 billion USD by 2035. The consumption of pharmaceutical gelatin, primarily driven by the increasing demand for capsules, tablets, and other formulations, is expanding globally. Porcine gelatin continues to be a key contributor due to its versatility and gel strength. In contrast, Bovine gelatin offers a strong market presence, valued for its diverse applications in both pharmaceuticals and nutraceuticals.
Fish gelatin is gaining traction as a preferred alternative due to its vegetarian-friendly properties and is considered an emerging choice for manufacturers. The emphasis on health and wellness trends has led to the increasing adoption of alternative sources, creating new opportunities within the market. Furthermore, the growth drivers include advancements in the pharmaceutical sector and rising research and development activities focusing on innovative gelatin-based products. However, regulatory challenges and fluctuating raw material prices may present obstacles.Overall, the segmentation of the Global Pharmaceutical Gelatin Market provides a comprehensive view of its dynamics and pivotal contributions across different source categories.
The Global Pharmaceutical Gelatin Market is forecasted to be valued at 3.35 USD Billion in 2024, reflecting a growing demand driven by diverse applications in the pharmaceutical and nutraceutical industries. The Product Type segment is divided primarily into Type A and Type B gelatin, each serving unique functions in drug formulation and delivery. Type A gelatin, derived from porcine sources, is often preferred for its gelling properties and clarity, making it vital in the production of capsules and soft gels.
Conversely, Type B gelatin, sourced from bovine, is typically used in hard-gelatin capsules and is important in providing stability and preventing moisture loss, which is essential for long-term product efficacy. The significance of these types is underscored by their ability to meet specific regulatory requirements and the growing trend towards vegetarian and vegan alternatives, presenting ample opportunities for market growth. Given the increasing prevalence of chronic diseases and the demand for advanced drug delivery systems, the Global Pharmaceutical Gelatin Market is poised for notable expansion in the coming years, with a projected Compound Annual Growth Rate of 4.43 from 2025 to 2035.
The Global Pharmaceutical Gelatin Market, primarily categorized by End Use, is expected to achieve a valuation of 3.35 USD Billion in 2024, showcasing its robust significance in various industries. The segmentation is predominantly divided into Pharmaceuticals, Nutraceuticals, and Cosmetics, each holding a pivotal role in the market dynamics. The Pharmaceuticals segment remains a crucial driver, with gelatin being extensively utilized in capsules and various formulations due to its biocompatibility and versatility. Nutraceuticals are also experiencing notable growth, fueled by the rising consumer awareness regarding health supplements and dietary products that utilize gelatin for improved bioavailability.
The Cosmetics sector benefits from gelatin’s unique properties, enhancing product performance in skincare and beauty formulations. The Global Pharmaceutical Gelatin Market data reflects an ongoing trend towards natural ingredient sourcing, fostering innovation within these end-use categories. Moreover, increased demand for vegetarian and vegan alternatives presents an opportunity within the gelatin market, further driving market growth in the upcoming years. Overall, the continuous expansion of these sectors underlines the significance of the Global Pharmaceutical Gelatin Market in meeting both consumer and industry needs effectively.
The Global Pharmaceutical Gelatin Market reflects a diverse landscape across various regions, with the market projected to reach a valuation of 3.35 USD Billion in 2024. Among the regions, North America leads, commanding a notable 1.3 USD Billion share in 2024, expected to grow to 2.1 USD Billion by 2035, showcasing its majority holding in the market. Europe follows with significant contributions of 0.9 USD Billion in 2024 and an anticipated rise to 1.5 USD Billion by 2035, driven by robust pharmaceutical production.
The Asia-Pacific region (APAC), valued at 0.8 USD Billion in 2024, is projected to expand to 1.3 USD Billion by 2035, reflecting its growing pharmaceutical industry and increasing demand for gelatin-based products. South America and the Middle East and Africa (MEA) represent smaller segments, valued at 0.25 USD Billion and 0.1 USD Billion respectively, in 2024, with expected growth to 0.4 USD Billion and 0.2 USD Billion by 2035. These regions face unique challenges but also present opportunities for market players to expand their footprint. The market growth is driven by the rising demand for gelatin in drug formulation and the increasing trend toward vegan alternatives, although competition and regulatory challenges present ongoing hurdles. Overall, the Global Pharmaceutical Gelatin Market statistics underscore a healthy and growing industry, with North America and Europe dominating the landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Global Pharmaceutical Gelatin Market is characterized by a dynamic landscape where companies are striving to establish a stronghold through strategic initiatives and product offerings. This market has gained traction due to the increasing demand for pharmaceutical applications, specialty formulations, and advancements in medical technology. Competitive insights reveal that players are leveraging innovation to develop high-quality, bio-compatible gelatin products to meet the diverse needs of the pharmaceutical industry.
The growing prevalence of chronic diseases and the aging population further drive the demand, making it essential for manufacturers to adapt to changing regulations and customer expectations. The competitive rivalry is enhancing as companies focus on expanding their geographic presence and investing in research and development to improve the properties of their gelatin products. Hence, an evolving competitive framework emerges.Ewald Gelatine has cemented its position within the Global Pharmaceutical Gelatin Market by emphasizing superior product quality and a commitment to sustainable practices.
The company boasts a strong production base and market presence, which is enhanced by its longstanding reputation for reliability and excellence. Ewald Gelatine focuses on harnessing advanced manufacturing techniques to produce gelatin that meets stringent pharmaceutical standards. The company is renowned for its contributions to various applications within the pharmaceutical sector, including the production of encapsulated medicines and biopharmaceutical products. With a robust distribution network and an emphasis on customer satisfaction, Ewald Gelatine continues to showcase its strengths in growing its market share and customer loyalty in a competitive landscape.Novozymes operates as a key player in the Global Pharmaceutical Gelatin Market, focusing on biotechnology solutions that integrate sustainable practices into gelatin production.
The company emphasizes innovation in its product offerings, including a range of enzymatic solutions tailored for the pharmaceutical industry. Novozymes’ strengths lie in its commitment to research and development, ensuring that its products not only meet regulatory standards but also enhance production efficiency and product efficacy for its clients. The company has been active in forming strategic partnerships and engaging in mergers and acquisitions to broaden its technological portfolio and expand its market reach. By consistently delivering tailored solutions that enhance health and wellness, Novozymes strengthens its position in the global market, catering to an evolving customer base that values both quality and sustainability.
The Global Pharmaceutical Gelatin Market has seen notable developments, particularly with ongoing innovations and increasing demand in the pharmaceutical sector. Noteworthy companies like Ewald Gelatine, Rousselot, and GELITA AG are investing in Research and Development to improve product offerings, primarily due to the rising need for gelatin in drug formulation and delivery systems. In recent months, the market has experienced significant growth, driven by the rising demand for capsules and soft gels, especially in developing countries.
In August 2023, Ewald Gelatine announced a strategic partnership with a leading pharmaceutical firm to enhance production capabilities, aiming to meet the surging demand. Additionally, Fujian Jumbo Grand and Kraton Corporation are advancing their manufacturing technologies to improve efficiency and sustainability in gelatin production. In an important development, in June 2023, it was announced that PB Gelatins had completed its acquisition of a competitor, enhancing its market share and production capacities. Over the past couple of years, the market has consistently demonstrated a positive trajectory, influenced by the expansion of the biopharmaceutical sector, particularly in Europe and North America. The increased use of gelatin in vaccine formulations further underscores its significance in the healthcare landscape globally.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 3.21(USD Billion) |
| MARKET SIZE 2024 | 3.35(USD Billion) |
| MARKET SIZE 2035 | 5.4(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.43% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Ewald Gelatine, Novozymes, GELATINOSO, Fujian Jumbo Grand, Rousselot, Kraton Corporation, PB Gelatins, Collagen Solutions, Ashland, Nitta Gelatin, Shenguan Holdings, Weishardt, GELITA AG, Gelita |
| SEGMENTS COVERED | Application, Source, Product Type, End Use, Regional |
| KEY MARKET OPPORTUNITIES | Increasing demand for capsule production, Growth in biopharmaceuticals sector, Rising consumer preference for vegetarian alternatives, Expanding markets in developing countries, Technological advancements in gelatin extraction. |
| KEY MARKET DYNAMICS | increasing demand for capsules , growth in nutraceuticals industry , rising healthcare expenditures , advancements in manufacturing technology , strict regulatory guidelines |
| COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
Pharmaceutical Gelatin Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Pharmaceutical Gelatin Market is projected to be valued at 3.35 USD Billion in 2024.
By 2035, the Global Pharmaceutical Gelatin Market is expected to reach 5.4 USD Billion.
The expected compound annual growth rate for the Global Pharmaceutical Gelatin Market from 2025 to 2035 is 4.43%.
North America is anticipated to have the largest market value in the Global Pharmaceutical Gelatin Market, estimated at 1.3 USD Billion in 2024.
The Capsules application segment is projected to generate the highest value in the Pharmaceutical Gelatin Market, estimated at 1.2 USD Billion in 2024.
The expected market size for Tablets in the Pharmaceutical Gelatin Market is projected to be 1.55 USD Billion by 2035.
Major players in the Global Pharmaceutical Gelatin Market include Ewald Gelatine, Novozymes, and Rousselot among others.
The Suppositories segment in the Pharmaceutical Gelatin Market is expected to reach a value of 1.15 USD Billion by 2035.
The market value for the APAC region in the Global Pharmaceutical Gelatin Market is estimated at 0.8 USD Billion in 2024.
Growth opportunities in the Global Pharmaceutical Gelatin Market include increasing demand for gelatin in drug formulations and advancements in pharmaceutical applications.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
